title: Ibrutinib in the real world patient: many lights and some shades.
authors.affiliation: Strategic Research Program on CLL and B Cell Neoplasia Unit, Division of Experimental Oncology, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy ghia.paolo@hsr.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Ghia
authors.affiliation: Department of Medical Sciences, Hematology Unit. University of Ferrara, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Cuneo
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000367:Age Factors; D000068456:Clinical Studies as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D010880:Piperidines; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D013548:Sweden; D006113:United Kingdom
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine